Muscle Oxygenation, Type 1 Diabetes, and Glycated Hemoglobin

NCT02051504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2026-05-14

No results posted yet for this study

Summary

Most of the studies concerning aerobic fitness in Type 1 diabetic patients noted a relationship between impaired aerobic fitness and high glycated haemoglobin (HbA1c) levels, reflecting poor long term glycaemic control. To explain this relationship, the indirect effect of chronically high blood glucose levels on cardiovascular complications - and hence on exercise cardiovascular adaptations - are often mentioned. However, one could wonder if HbA1c could also have a direct impact on aerobic fitness patients with Type 1 diabetes. Haemoglobin glycation may increase its O2 affinity, thus limiting the O2 availability at the muscular level and impairing maximal aerobic power. Moreover, chronic hyperglycaemia might have deleterious effect on muscle mitochondrial capacity to use O2. The aim of this study is to assess the effect of Type 1 diabetes and of HbA1c level on muscular oxygen delivery and use and hence on aerobic fitness.

Conditions

Interventions

BEHAVIORAL

Incremental maximal exercise

The exercise test starts 2-4h after a standardised breakfast. After a 2-min resting period sitting on the cycle ergometer (Excalibur Sport, Lode B.V, Medical Technology, Groningen, Netherlands), the test starts at 30 watts with a 20 watts increment every 2min until exhaustion.

DIETARY_SUPPLEMENT

Oral Glucose Tolerance Test

The subjects arrive after an overnight fast and have a 75g Glucose Oral Charge.

PROCEDURE

Muscle biopsy

A sample of vastus lateralis (less than 150mg) is taken with a specific needle under local anesthesia.

PROCEDURE

Combined DLCO-DLNO

Lung carbon monoxide and nitric oxide diffusion capacities are assessed at rest in a sitting position.

PROCEDURE

Dual energy X-ray absorptiometry

Body composition is measured using dual energy X-ray absorptiometry at rest.

PROCEDURE

Accelerometry over one week

The subjects wear an uniaxial accelerometer over one week to assess their usual physical activity level

OTHER

Questionnaires

Diet questionnaire, quality-of-life questionnaires, physical activity questionnaires

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Elsa HEYMAN, PHD · EA4488 'Physical activity, Muscle, Health

  • Pierre FONTAINE, MD-PHD · CHRU LILLE

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02051504 on ClinicalTrials.gov